Penny stock player Adamis gets another CRL for high-dose naloxone as shares crater
The FDA has once again shut the door on micro cap biotech Adamis Pharmaceuticals’ high dose naloxone injection.
Regulators handed down the program’s
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
